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Moloney murine leukemia virus (Mo-MuLV) is a thymotropic and leukemogenic retrovirus which causes T lymphomas
and leukemias, yet does not contain a transforming gene product. Mo-MuLV has been shown to trans-activate cellular
genes via a polymerase III-generated transcript, designated let, from the long terminal repeat (LTR). Here we demonstrate
that introduction of the Mo-MuLV LTR stably, or transiently, into murine or human cultured cells resulted in an 8- to 15-
fold increase in collagenase IV (92-kDa gelatinase, gelatinase B, matrix metalloproteinase-9) gene expression. Collagenase
IV protein expression was induced 9-fold by stable integration of MuLV LTR, as measured by immunoblot analysis using
an anti-collagenase IV polyclonal antibody. The MuLV LTR coordinately stimulated the proteolytic activity of collagenase IV
by 14-fold. The AP-1-binding site in the collagenase IV promoter was required for transactivation by the LTR. Collagenase
type IV degrades type IV collagen, a major component of basement membrane, which constitutes the first step of the
metastatic cascade. The activation of proteolytic enzymes by the MuLV LTR may thus play a contributory role in the
development or spread of virus-induced lymphomas or leukemias. q 1997 Academic Press
INTRODUCTION Koka et al., 1991; Faller et al., 1988; Weng et al., 1995).
The introduction of the virus transiently, or stably, into
Moloney murine leukemia virus (Mo-MuLV) is a thymo-
the cells also stimulates c-jun gene expression (Weng
tropic and leukemogenic retrovirus which causes T cell
et al., 1995). The expression of a subgenomic portion of
lymphoblastic lymphomas and granulocytic/myeloid leu-
Mo-MuLV, the LTR, has been shown to be sufficient forkemias (Fan, 1990; Nazarov et al., 1994; Belli et al., 1995;
this effect (Choi and Faller, 1995, 1994).Shen-Ong and Wolff, 1987). Unlike acutely transforming
Transient or stable expression of the Mo-MuLV viralretroviruses, MuLV does not contain an oncogene which
LTR increases cellular AP-1 DNA-binding activity and thecan transform normal cells. The mechanism(s) by which
expression of some AP-1-responsive genes (Weng et al.,MuLV causes leukemia is thus not clear. Multiple molec-
1995). The collagenase type IV gene is an AP-1-inducibleular mechanisms may contribute to Mo-MuLV-induced
gene in some cell lineages (Angel et al., 1987; Schonthalleukemogenesis, including insertional activation of cellu-
et al., 1988; Chamberlain et al., 1993; Sato et al., 1993;lar proto-oncogenes by enhancers or promoters located
Gack et al., 1994; Angel and Karin, 1992). The role of typewithin the retroviral long terminal repeat, generation of
IV collagenase in mediating tumor metastasis and tumorenvelope gene recombinants, and a preleukemic state
invasion has been extensively studied (Alexander andcharacterized by generalized hematopoietic hyperplasia
Werb, 1992; Gray et al., 1992; Stearns and Stearns, 1993;and splenomegaly (Davis et al., 1987; Li and Baltimore,
Karelina et al., 1993; Paine et al., 1993; Darmiento et al.,1991; Hayward et al., 1981; Fan, 1990; Brightman et al.,
1995; Devarajan et al., 1992). Collagenase type IV has1990; Cuypers et al., 1994; Rommelaere et al., 1978).
been shown to degrade type IV collagen, a major compo-We have previously reported that Mo-MuLV profoundly
nent of basement membrane, which constitutes the firstaffects the regulation of certain cellular genes. Mo-MuLV
step of the metastatic cascade (Liotta et al., 1987). Re-trans-activates specific cellular genes including major
cently, collagenase type IV has been found to play a rolehistocompatibility (MHC) genes and genes encoding a
in leukemogenesis. The 92-kDa collagenase IV enzymenumber of other T cell activation antigens (Flyer et al.,
can be induced in myeloid and T lymphoid cell lineages1985; Choi and Faller, 1995, 1994; Wilson et al., 1987;
(Pourmotabbed et al., 1994; Weeks et al., 1993b; Devara-
jan et al., 1992) and may play a role in normal neutrophil
1 To whom correspondence and reprint requests should be ad- and lymphocyte chemotaxis and diapedesis (Xia et al.,dressed at Cancer Research Center, Boston University School of Medi-
1996). Increased expression and secretion of the 92-kDacine, 80 E. Concord St., Room K-701, Boston, MA 02118. Fax: (617) 638-
4176. collagenase IV mediates or facilitates leukemic cell inva-
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sion of tissues and extramedullary tumor formation (Ko- and acetyl-CoA were obtained from Sigma. [14C]Chloram-
phenicol was obtained from New England Nuclear.bayashi et al., 1995; Watanabe et al., 1993; Hendrix et
al., 1992). Infection with the HIV-1 retrovirus was also
RNA blot analysisfound to stimulate collagenase type IV activity, which
may contribute to T lymphocyte invasion and cause the Total cellular RNA was isolated by guanidine thiocya-
tissue-specific localization of HIV-1-infected lymphoid nate/phenol RNA extraction (Flyer et al., 1983), quantified,
cells (Weeks et al., 1993a). separated by electrophoresis on formaldehyde agarose
In this report, we show activation of the collagenase gels, and transferred to BioBlot-supported nitrocellulose
IV gene as a trans-effect of retrovirus infection, that the (Costar, Cambridge, MA). Hybridizations were carried out
retroviral LTR alone is sufficient for activation of collagen- under stringent conditions, at 427 in 50% formamide for
ase IV, and that the transcriptional activation requires a 18 hr. The filters were washed sequentially in 21 SSC–
functional AP-1-binding site in the promoter. Immunoblot 0.5% SDS and in 0.21 SSC–0.1% SDS, at room tempera-
analysis demonstrated that type IV collagenase gene ex- ture and at 427, respectively. Autoradiograms were densi-
pression and protein expression were greatly increased tometrically scanned for quantitation, using an LKB laser
in cells with an integrated Mo-MuLV LTR. Zymographic densitometer (Upsalla, Sweden).
assays showed that the presence of the Mo-MuLV LTR
coordinately stimulated cellular collagenase IV proteo- a-32P-labeled DNA probes
lytic activity. These findings suggest a possible role for
The collagenase IV probe was a 2.2-kb EcoRI fragmenttype IV collagenase in mediating the spread of Moloney
purchased from ATCC, and the actin probe was a 0.7-kbmurine leukemia virus-induced leukemias and lym-
PstI fragment of murine b-actin. The collagenase IV RNAphomas.
probe was made from the pGEM T7 promoter using T7
RNA polymerase (Promega). A purified fragment of b-
MATERIALS AND METHODS actin cDNA was radio-labeled with [a-32P]dCTP using
random-primer synthesis (Feinberg and Vogelstein,
Cell culture and reagents 1983).
The mouse fibroblast cell line Balb/c-3T3 and the hu-
Transfection and infection of cells
man cervical carcinoma cell line HeLa were obtained
from American Type Culture Collection (Rockville, MD). Transient transfections were performed using the
DEAE–dextran method (Oprian et al., 1987). Cells wereBalb/c-3T3 cells and a Moloney-MuLV-infected Balb/c-
3T3 cell line (MoBalb) (Flyer et al., 1983) were carried in seeded in 60-mm dishes at 3 1 106 the day before trans-
fection. Five micrograms of CAT-containing reporter plas-Dulbecco’s modified Eagle’s medium (DMEM) supple-
mented with 10% heat-inactivated donor bovine calf mids was transfected together with 5 mg of LTR vector
or control plasmid (pBR322). All plasmids for transfectionserum (Sigma Chemical Co., St. Louis, MO), 2 mM L-
glutamate, 100 units of penicillin/ml, and 100 mg of strep- were purified by equilibrium banding in cesium chloride.
The vector pCollCat-73 (Angel et al., 1988) was the gener-tomycin/ml. The HeLa cells were grown in DME supple-
mented with 10% heat-inactivated newborn calf serum ous gift of P. Angel. pMoV9, a plasmid containing a
cloned provirus of Mo-MuLV, was the gift of R. Jaenisch(Sigma). HeLa or Balb/c cells stably transfected with the
(LTR-containing) pZip-Neo-SV(X) vector were maintained (Chumakov et al., 1982). p623, a proviral clone of AKV
(Lowy et al., 1980), and a cloned amphotropic MuLV pro-in DMEM supplemented with 10% heat-inactivated new-
born calf serum, 0.5 mg of Geneticin/ml, and glutamine virus (Chattopadhyay et al., 1981), were the generous
gifts of D. Lowy. pXF-MoA is a pMoV9 derivative con-plus antibiotics as above. pZip-Neo-SV(X) (Cepko et al.,
1984) (provided by C. Cepko) is a vector which contains taining only the 5* LTR portion including 250 bp of cellular
sequence and a SV40 polyadenylation signal sequencethe 5* LTR of Mo-MuLV and 5* genomic sequences up
to base 739 (using the nucleotide numbering system of in the pBR325 (Petrarca et al., 1988) (see Fig. 2A). The
plasmid pML4 contains a single intact LTR and 214 bpShinnick (Shinnick et al., 1981)), the 3* region of Mo-
MuLV from bases 7200 and including the 3* LTR, and of viral genomic sequence upstream of the 3* LTR (Choi
and Faller, 1995, 1994). The 3* deletion mutant vectoralso Mo-MuLV bases from 5407 to 5766. In addition, this
vector also contains the prokaryotic gene from transpo- pGUXDP is a pXF-MoA derivative with a deletion of
EcoRV–EcoRV (75 bp) and DdeI–MboI (15 bp) in the U3son Tn5, which confers resistance to neomycin, the
pBR322 origin of replication, and the SV40 origin of repli- region, in a pGEM3 vector (Choi and Faller, 1995). The
DEAE–dextran transfection mix contained 0.1 M Tris, pHcation. Cells stably transfected with a single copy of the
LTR-containing construct pML4 and a Neo-resistance 7.4, 2.5 mg/ml DEAE–dextran, and 10 mg of transfected
DNA. Cells were rinsed twice with PBS (phosphate-buf-vector, or the Neo-resistance vector alone, have been
previously described (Choi and Faller, 1994). Geneticin fered saline) to remove excess amounts of serum which
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might interfere with transfection efficiency. The transfec- for 2 min. A final 5 min of extension reaction was per-
formed at 727. The products of amplification were sepa-tion mixture was slowly added to the plates. The cells
were incubated at 377 for 4 hr. After incubation, the trans- rated on 1% NuSieve agarose gel in 11 Tris/acetate/
EDTA buffer. The electrophoresis was run for 2 hr at 100fection mixture was removed, and the cells were rinsed
with PBS twice and then replenished with growth me- V, stained with ethidium bromide, and then photo-
graphed.dium.
For stable transfections, the retroviral vector pZip-Neo-
CAT reporter gene assaySV(X) was transfected into a canine cell amphotropic
packaging line (DAMP) and filtered supernatants con-
For preparation of cell extracts, cells were scraped off
taining packaged vector were used to infect Balb/c-3T3
the plate in 1 ml ice-cold PBS, pelleted by centrifugation,
and HeLa cells (Choi and Faller, 1994). After infection,
and then resuspended in 250 mM Tris–Cl, pH 7.4. The
neomycin-resistant colonies were selected and cloned
cells were frozen in dry ice and thawed at 377 three
as follows. The transfected or infected cells were incu-
times, then centrifuged at 15,000 rpm in a microfuge for
bated in the fresh medium for 2 days and then transferred
10 min at 47. The supernatant fraction was collected and
to medium containing G418. After about 2 weeks incuba-
the protein concentration was measured by the Bradford
tion with the selection medium, the colonies were col-
method using a Bio-Rad solution (Richmond, CA). The
lected using sterile cloning cylinders by trypsinization
CAT activity was quantitated in extracts as described
and then transferred to 24-well plates and replenished
(Gorman et al., 1982). One hundred micrograms of total
with growth medium.
protein was incubated with 15 ml of CAT mixture con-
The mutation of the AP-1-binding site in pCollCAT-73
taining 0.1 mCi/ml [14C]chloramphenicol and 0.1 mg/ml
to create the plasmid pmutCollCAT-73 was performed
acetyl-CoA at 377 for 2 hr. The reaction mixture was ex-
using two synthetic oligonucleotides of 18 bases in
tracted with 1 ml 100% ethyl acetate, vortexed, and sepa-
length, encompassing the HindIII site on pCollCAT-73 to
rated by centrifugation for 2 min. The supernatants were
the XbaI site at /74. The 5* primer contained a complete
dried in a vacuum centrifuge. Fifteen microliters of ethyl
HindIII site, and the 3* primer contained a complete XbaI
acetate was added to the dried supernatant in each tube
site. The fragment containing the mutation was gener-
and vortexed. The reaction mixture was loaded onto a
ated by synthesizing two overlapping fragments, denatur-
TLC (thin-layer chromatography) plate and then sepa-
ing, and then annealing. Complementary strands were
rated in chloroform:methanol (19:1) in a sealed chamber
synthesized from the overhangs of the two annealed frag-
for about 15 min. The TLC plate was then removed, air
ments, and ligation and transformation of bacteria were
dried, and exposed to Kodak X-ray film. Reaction prod-
carried out. The mutation was confirmed by chain-termi-
ucts were quantitated using an LKB laser densitometer.
nation DNA sequencing (Sanger et al., 1977).
Cotransfection with the pRSV-b-galactosidase plasmid
(0.5 mg per transfection) and cytofluorometric analysis of
Reverse transcriptase–PCR b-galactosidase activity were performed to normalize the
transfection efficiency, as described (Choi and Faller,
Total RNA was isolated from Balb/c-3T3 or HeLa cells
1994). b-galactosidase activity was determined by using
using the guanidine thiocyanate method (Chirgwin et al.,
the fluorogenic substrate FDG (fluorescein di-(b)-D-ga-
1979). The RNA resulting preparation was treated with
lactopyranoside). The fluorescence was measured by a
RQ RNase-free DNase (1 mg/mg RNA) for 1 hr at 377
Cytofluor plate fluorocytometer (Millipore).
to eliminate contaminating DNA and then repurified by
phenol/chloroform extraction and ethanol precipitation. Collagenase enzymatic activity assay (zymography)
RT–PCR was performed using oligonucleotides comple-
mentary to the MuLV LTR transcript. The primers used For preparation of cellular protein lysates, cells were
rinsed twice with PBS, scraped off the plates in 1 mlfor RT–PCR have been detailed previously (Choi and
Faller, 1995). LTR-specific oligonucleotide primer D2, PBS, washed three more times with PBS, and then resus-
pended in 500 ml ddH2O. The cells were frozen in thewhich is complementary to nt 390 to 410, was used for
first-strand cDNA synthesis. The template cDNAs ob- dry ice then thawed at 377. The freeze and thaw cycle
was repeated twice. The cell debris was first removedtained were amplified using primer C2, which is homolo-
gous to nt 270 to nt 280 in the LTR. In some control by centrifugation at 15,000 rpm for 10 min in a microfuge
and further in a Sorvall centrifuge at 10,000 rpm for 45reactions, a wrong strand primer, D1, homologous to nt
561 to nt 581 in the LTR was used in place of C2. The min. The total protein concentration was determined by
a Bradford assay. Fifty micrograms of total protein wasPCR was performed in a Perkin–Elmer thermocycler. The
reaction mixture was denatured at 957 for 2 min and then loaded into each well. The proteins were separated in a
10% polyacrylamide gel (SDS–PAGE) containing 1 mg ofthe following cycle was repeated 30 times: heat denature
at 957 for 1 min, anneal at 607 for 1 min, and extend 727 gelatin/ml, at 40 V for 18 hr in the presence of SDS,
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but the protein was not heat-denatured or chemically
denatured by b-mercaptoethanol prior to loading. After
electrophoresis, the gel was washed in 2.5% Triton X-
100 for 30 min and then incubated at 377 in 50 mM Tris –
HCl, pH 7.6, containing 50 mM CaCl2 , 10 mM NaCl, and
0.05% NaN3 for 18 hr. A staining solution containing 20%
methanol, 80% acetic acid, and 0.25% Coomassie blue
was used to stain the gels. The gel was later destained
by a destaining solution containing 20% methanol and FIG. 1. Analysis of collagenase IV transcripts in Balb or HeLa cells
80% acetic acid. The gelatinolytic activity was evident as expressing Mo-MuLV or Mo-MuLV LTRs. Total cellular RNA (20 mg)
was obtained from cultured cells or cultured cells infected with Mo-a clear band against the blue background of the stained
MuLV or expressing the Mo-MuLV LTRs. Lane 1, Balb cells; lane 2,gelatin.
Balb cells infected with Mo-MuLV; lane 3, Balb cells stably transfected
with one copy of the LTR-expressing vector pZip-Neo-SV(X); lane 4,Immunoblot analysis
HeLa cells; lane 5, HeLa cells stably transfected with one copy of
the LTR-expressing vector pZip-Neo-SV(X). RNA was separated on aCells were scraped off of plates into 1 ml ice-cold PBS,
formaldehyde–agarose gel, transferred to a nitrocellulose filter, andwashed twice with PBS, and the cell pellets were then hybridized with labeled collagenase IV or b-actin probes. The figures
resuspended in solubilizing buffer containing 1% Triton- are autoradiograms. The migration positions of the 28s and 18s rRNAs,
X 100, 50 mM ZnCl2 , 25 mM MgCl2 , 1 mM DTT, 1 mM and collagenase IV and b-actin transcripts are indicated.
PMSF, incubated on ice for 5 min, and then centrifuged
at 15,000 rpm in a microfuge for 10 min. One hundred
1995)). To determine whether the Mo-MuLV LTR alonemicrograms of total protein was loaded into each well of
could activate the collagenase IV gene, the packagedan 10% SDS–PAGE gel. After electrophoresis at 40 V for
defective retroviral vector pZip-Neo-SV(X) (see Fig. 2A for18 hr in Tris–glycine buffer containing 25 mM Tris, 250
map), which contains two LTRs but no structural viralmM glycine, 0.1% SDS, the proteins were transferred to
sequences, was used to infect Balb cells. After neomycina nitrocellulose filter in a semidry protein transfer appara-
selection, the resulting cells had an average of two cop-tus. The immunoblotting nitrocellulose filter was soaked
ies of the Mo-MuLV LTR stably integrated in their ge-in transfer buffer containing contained 0.5 % glycine, 10
nomes (Weng et al., 1995). The expression of collagenasemM Tris, 1% SDS, and 20% methanol. The transfer was
IV mRNA was elevated 12.2-fold ({ 2.6, SEM) in Balb/c-carried out at 0.8 mA/cm2 for about 1.5 hr. The filter was
3T3 cells with integrated Mo-MuLV LTRs, compared toblocked in TTBS solution, containing 50 mM Tris, 0.05%
the expression of the control gene b-actin (Fig. 1). Induc-Tween 20, and 0.5 M NaCl, pH 7.5, for 1 hr. After blocking,
tion of specific cellular gene transcripts by the Mo-MuLVthe filter was incubated in TTBS-blocking solution con-
LTR was not restricted to murine cells. HeLa cells stablytaining 1 mg/ml goat anti-human collagenase IV antibody
expressing the Mo-MuLV LTR also demonstrated an atfor 30 min. The blot was washed twice for 15 min with
least 16-fold induction of collagenase IV transcripts rela-TTBS. The goat primary antibody was detected with a
tive to HeLa cells without the LTR. In contrast, the levelsbiotinylated mouse anti-goat immunoglobulin G-alkaline
of other gene transcripts, including b-actin and GAPDHphosphatase complex and substrate kit (Vector Labora-
(not shown), did not increase significantly in response totory).
the Mo-MuLV LTR.
Collagenase promoter-driven reporter gene (CAT)RESULTS
assays were performed to demonstrate trans-activation
of an exogenous collagenase IV gene promoter–reporterWe have previously shown that stable infection of
Balb/c-3T3 cells with Mo-MuLV results in the induction construct by an integrated Mo-MuLV LTR. Plasmid pColl-
CAT-73 contains 73 bp of the collagenase IV promoterof transcripts for specific cellular genes, including class
I MHC (Flyer et al., 1985; Wilson et al., 1987; Faller et driving the reporter gene CAT (see Fig. 2A) (Angel et
al., 1987, 1988). Five micrograms of pCollCAT-73 wasal., 1988; Choi and Faller, 1994, 1995), T cell activation
antigens (Koka et al., 1991), MCP-1 (Weng et al., 1995), transiently transfected into Balb/c-3T3 cells or into Balb/
c-3T3 cells containing two stably integrated LTRs (Fig.and c-jun (Weng et al., 1995) as a result of AP-1 activation
(Weng et al., 1995). RNA blot analysis demonstrated that 2B). Transient transfection of pCollCAT-73 into the control
Balb/c-3T3 cells generated only low levels of basal CATtranscript levels for collagenase IV were elevated at least
13-fold in cells containing the Mo-MuLV genome (Fig. 1). activity, but cotransfection of the same reporter plasmid
into Balb/c-3T3 cells containing the integrated MuLVWe have previously shown that the entire leukemia virus
is not required for trans-activation of certain of these LTRs resulted in a 16.3-fold ({ 2.9) relative increase in
collagenase IV promoter-driven CAT activity. Similar lev-cellular genes (e.g., class I MHC, c-jun, and MCP-1 (Koka
et al., 1991; Choi and Faller, 1994, 1995; Weng et al., els of induction of collagenase IV promoter activity [14.1-
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fold ({ 4.1)] were observed using HeLa and LTR-express-
ing HeLa cells as the transfected cell lines. Thus, the
Mo-MuLV LTR alone, without the whole virus, is sufficient
to activate collagenase IV gene transcription.
The LTR-encoded transactivator of MuLV, let, resides
within the U3 region of LTR, unlike the tat or tax transacti-
vators of HIV and HTLV (Choi and Faller, 1995; Choi and
Faller, 1994). To determine whether the let transcript from
the Mo-MuLV LTR, which has been shown to be respon-
sible for MuLV LTR transactivation, was made in these
Balb/c-3T3 or HeLa cell lines expressing the LTR-con-
taining vector, total RNA was isolated from the untrans-
fected control lines or the lines expressing the Mo-MuLV
LTR and treated with DNase. Reverse transcriptase was
used to generate single-strand complementary cDNA
and then used as template for PCR amplification. The
LTR-specific oligonucleotide primer D2, which was com-
plementary to nt 390 to 410 was used for first-strand
cDNA synthesis. The template cDNAs obtained were am-
plified using primer C2, which is homologous to nt 270
to nt 280 in the LTR. Reactions using C2 and D2 gener-
ated the predicted product of 141 bp (Fig. 3). This frag-
ment was detected in Balb/c-3T3 and HeLa cells ex-
pressing the MuLV LTR retroviral vector but not in the
Balb/c-3T3 or HeLa cells without the MuLV LTR. As a
control, RT–PCR without reverse transcriptase did not
generate this product, suggesting that the product was
amplified from reversed-transcribed cDNA rather than
from a contaminating DNA template. No product was
generated using RNA from LTR-containing Balb/c-3T3
cells using mismatched (same-strand) primers (D1, D2),
suggesting PCR product was generated specifically by
this set of LTR-specific primers. No product was gener-
ated in the absence of RNA template.
The plasmid pML4, which contains only the 3* LTR
region of MuLV, was utilized to determine whether aFIG. 2. (A) Schematic drawings of the reporter genes and the LTR
expression vectors. pCollCAT-73 contains an intact AP-1 site; pmutColl- transiently expressed (nonintegrated) LTR could activate
CAT-73 contains a mutated AP-1 site with a mutation of TGAGTCA to the human collagenase IV promoter (Fig. 4A). Balb/c-
TGAGTAC. The structures of the Mo-MuLV provirus (pMoV9) and the 3T3 cells were transiently transfected with pCollCAT-73
vector pZip-Neo-SV(X) are shown. Also depicted are the various vectors
together with a control plasmid (pBR322). The CAT activ-derived from the Mo-MuLV provirus and Mo-MuLV LTR (Mo-LTR), in-
ity generated by cotransfection of pCollCAT-73 with thecluding pML4, pXFMoA, pML4, pMoV9, and pGUXDP (see (Choi and
Faller, 1994) for description). The open bar represents the LTR of Mo- control (backbone) plasmid pBR322 was relatively low.
MuLV and its flanking proviral sequences, and the thinner bar the Cotransfection of pCollCAT-73 with the entire Mo-MuLV
adjacent cellular sequences. (B) Induction of transiently expressed col- provirus (pMoV9) increased the CAT activity driven by
lagenase IV gene promoter activity by a stably integrated Mo-MuLV
the collagenase IV promoter by 11.6-fold ({ 3.2). Cotrans-LTR. The plasmid pCollCAT-73 (5 mg) together with pRSV-Gal (1 mg)
fection of pCollCAT-73 with the LTR-containing plasmidas internal control were transiently transfected into Balb/c-3T3 cells
(lane 1); or Balb/c-3T3 cells containing two copies of a stably integrated pML4 increased the CAT activity driven by the collagen-
LTR (lane 2) or HeLa cells (lane 3); or HeLa cells containing two copies ase IV promoter by 15.1-fold ({ 3.9). The viral LTR alone
of a stably integrated LTR (lane 4). Forty-eight hours after transfection, was thus as potent as the entire proviral genome in in-
cells were harvested and extracts were normalized for transfection
ducing trans-activation of the collagenase IV gene pro-efficiency (as reflected by b-galactosidase activity) and then assayed
moter in transient expression assays. Parallel transfec-for CAT activity. The products were separated by thin-layer chromatog-
raphy. An autoradiogram of a chromatography plate is shown. The tions into HeLa cells demonstrated an 8-fold ({2.9) stim-
migration positions of chloramphenicol (Cam) and the acetylated prod- ulation of collagenase-promoter-driven CAT activity. The
ucts (AcCam) are indicated. This result is typical of the same or similar plasmid pML4 contains a 3* LTR, whereas the construct
experiments repeated at least three times and used for statistical
pXF-MoA contains a 5* LTR. Cotransfection of pXF-MoAanalysis.
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FIG. 3. RT–PCR analysis of RNA isolated from cells expressing a MuLV LTR. (A) Schematic diagram of the oligonucleotide primers and LTR viral
template for RT–PCR (Choi and Faller, 1995). The arrow over the U3 region indicates the initiation site and the direction of the novel LTR transcript
(let) (Choi and Faller, 1995). The ‘‘viral’’ RNA derived from the classical Pol II promoter, initiating in the U3 region of the LTR, and the novel let LTR
transcript, are depicted as thick lines. The 5* termini of these transcripts within the LTR region are shown by the open and filled circles, respectively.
Oligonucleotide D2 was used as a primer for the first-strand synthesis, and the resulting cDNAs were amplified using primer C2. In some reactions,
a ‘‘wrong strand’’ primer, D1, was used as a control in place of C2. The expected RT–PCR amplified product with the C2/D2 pair of primers is
indicated, as is the expected size (in bp) of the product. T, TATA box of classical genomic promoter; A, polyadenylation signal. (B) RT–PCR of total
RNA isolated from Balb/c-3T3 cells or Balb/c-3T3 cells containing a single copy of a vector expressing the MuLV LTR (pZip-Neo-SV(X)). Lane 1,
RT–PCR without the addition of cellular RNA; lane 2, RT–PCR using DNase-treated RNA isolated from LTR-expressing Balb/c-3T3 cells, using
mismatched primers; lane 3, RT–PCR using DNase-treated RNA isolated from LTR-expressing Balb/c-3T3 cells; lane 4, RT–PCR using DNase-
treated RNA isolated from (control) Balb/c-3T3 cells. Lane M consists of MW markers consisting of a 100-bp ladder of dsDNA molecular weight
markers (New England Biolabs). The position of the 143-bp amplified product is indicated. (C) RT–PCR of total RNA isolated from Balb/c-3T3 or
HeLa cells, and Balb/c-3T3 or HeLa cells containing a single copy of a vector expressing the MuLV LTR (pZip-Neo-SV(X)). Lane 1, RT–PCR using
RNA from Balb/c-3T3 cells; lane 2, RT–PCR using RNA from LTR-expressing Balb/c-3T3 cells; lane 3, RT–PCR using RNA from LTR-expressing
HeLa cells; lane 4, RT–PCR using RNA from LTR-expressing HeLa cells; lane 5, RT–PCR using RNA from LTR-expressing Balb/c-3T3 cells, without
the addition of reverse transcriptase; lane 6, RT–PCR using RNA from LTR-expressing HeLa cells, without the addition of reverse transcriptase;
lane M, MW markers consisting of a HaeIII digestion of f174 (New England Biolabs). The position of the 143-bp amplified product is indicated.
with pCollCAT-73 resulted in an induction of CAT activity transfection of pCollCAT-73 with the Mo-MuLV provirus
(pMoV9) increased the CAT activity driven by the colla-to a level equal to that induced by pML4 (Fig. 4B). Thus,
the MuLV LTR was able to activate the collagenase IV genase IV promoter, whereas transfection with the AKV
or Amphotropic MuLV proviral genomes did not result inpromoter when present endogenously (during stable ex-
pression, see Fig. 2) and when introduced exogenously transactivation, demonstrating some specificity of the
type of LTR for the transactivation process (Fig. 4C).(cotransfection of pML4 or pXF-MoA and the reporter
gene in transient expression assays). A mutant of pXF- Collagenase IV promoter–reporter genes with muta-
tions in the AP-1-factor-binding site were employed toMoA incapable of producing the let transcript, desig-
nated pGUXDP (Choi and Faller, 1995), was incapable determine if this binding site was required for trans-acti-
vation of collagenase IV by the viral LTR. The vectorsof transactivating the pCollCAT-73 construct (Fig. 4B),
demonstrating the requirement for the let transcript in pCollCAT-71, in which the first two bases of the TRE
consensus site are deleted, and pmutCollCAT-73, whichthis process. A number of relatively nonpathogenic vi-
ruses were tested for their ability to stimulate collagen- contains a transversion of the last two bases of the bind-
ing site (CA to AC) were used as reporter genes in co-ase IV gene expression. As shown above (Fig. 4A), co-
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FIG. 4. Activation of the collagenase IV gene promoter by LTR-expressing vectors and retroviral genomes in transient expression assays. (A)
Balb/c-3T3 cells were transiently transfected with 5 mg of the reporter vector pCollCAT-73 and 1 mg pRSV-Gal, together with 5 mg of: a control
plasmid pBR322 (lane 1); the plasmid pMoV9 (containing the Mo-MuLV provirus) (lane 2); or the plasmid pML4 (containing the Mo-MuLV LTR) (lane
3). HeLa cells were transiently transfected with 5 mg of the reporter vector pCollCAT-73 and 1 mg pRSV-b-Gal, together with 5 mg of: a control
plasmid pBR322 (lane 4); or the plasmid pML4 (containing the MuLV LTR) (lane 5). (B) Balb/c-3T3 cells were transiently transfected with 5 mg of
the reporter vector pCollCAT-73 and 1 mg pRSV-Gal, together with 5 mg of: a control plasmid pBR322 (C) (lane 1); the plasmid pML4 (ML4) (lane
2); the plasmid pXF-MoA (MoA) (lane 3); or the plasmid pGUXDP (XDP) (lane 4). (C) Balb/c-3T3 cells were transiently transfected with 5 mg of the
reporter vector pCollCAT-73 and 1 mg pRSV-Gal, together with 5 mg of: a control plasmid pBR322 (C) (lane 1); the plasmid pMoV9 (M) (containing
the MoMuLV proviral genome) (lane 2); the plasmid p623 (AKV) (containing the AKV MuLV proviral genome) (lane 3); or the plasmid containing the
Amphotropic MuLV proviral genome (Am) (lane 4). Forty-eight hours after transfection, cells were harvested and extracts were normalized for
transfection efficiency as reflected by b-galactosidase activity and were then assayed for CAT activity. The products were separated by thin-layer
chromatography, and an autoradiogram of a plate is shown here. The migration positions of chloramphenicol (Cam) and the acetylated products
(AcCam) are indicated. These results are typical of the same or similar experiments repeated three times, and used for statistical analysis.
transfections with the vector pML4. Both the deletion and that MuLV LTR not only activates the collagenase IV gene
transcriptionally, but it also results in collagenase IV pro-the transversion (mutant) AP-1 sites have been previously
shown to be incapable of binding AP-1 and incapable of tein synthesis.
The regulation of collagenase IV function and activitycompeting with a wild-type site for AP-1 binding (Weng
et al., 1995). Cotransfection of the viral LTR did not result is a multistep process. In addition to transcriptional and
translational regulation, the newly synthesized proenzymein trans-activation of CAT activity from these TRE-mutant
promoters (Table 1). requires cleavage at the N-terminus and must be dissoci-
ated from a tissue inhibitor to be functional (Goldberg etTo investigate whether the transcriptional activation of
collagenase IV by the LTR is paralleled by an increase of al., 1989; Liotta et al., 1987). Therefore, cellular gelatinolytic
activity was measured to determine whether the increasecollagenase IV protein expression, immunoblot analysis
was performed using an anti-human type IV collagenase of collagenase IV protein induced by MuLV LTR was re-
flected by increased collagenase IV enzymatic activity.monoclonal antibody. Immunoblot analysis of total cyto-
plasmic proteins from control HeLa cells showed that The proteolytic activity produced by fibroblasts alone or
by fibroblasts with an integrated MuLV-LTR was measuredthe amount of protein recognized by an anti-collagenase
IV antibody was weak but detectable, whereas in cell by zymography. After incubation at 377 for 18 hr in sub-
strate buffer, zymographic analysis showed a weakly di-lysates made from HeLa cells containing an integrated
MuLV LTR, the collagenase IV protein levels were 9- gested gelatin band at 92 kDa in lysates from control cells,
reflecting a low basal collagenase IV activity (Fig. 5B).fold higher than those in control HeLa cells (Fig. 5A), as
quantitated by densitometry. This experiment revealed However, the protein lysates made from cells with an
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TABLE 1 of genes belonging to the immunoglobulin superfamily
and involved in T-lymphocyte activation, including the
Relative CAT activity Class I MHC antigens (Flyer et al., 1985; Wilson et al.,
Reporter vector a LTRb ({SEM)c
1987; Faller et al., 1988; Choi and Faller, 1994; Koka et
al., 1991). Recently, we have reported that the LTR ofpCollCAT-60 0 1 ({0.6)
pCollCAT-60 / 3 ({1.1) Moloney MuLV encodes a trans-activator which induced
pCollCAT-71 0 2 ({0.9) transcription and expression of MHC Class I genes, T
pCollCAT-71 / 1 ({0.9) cell activation antigens, and certain cytokine genes (Choi
pCollCAT-73 0 8 ({2.6)
and Faller, 1995). MuLV was also found to transactivatepCollCAT-73 / 43 ({5.6)
transcription factor AP-1 and AP-1-inducible genes, suchpmutCollCAT-73 0 2 ({1.4)
pmutCollCAT-73 / 2 ({1.9) as c-jun and MCP-1 (Weng et al., 1995), as well as an-
other, previously unreported, transcription factor activity
a Five micrograms of the designated CAT-containing reporter plas- responsible for class I MHC gene induction (Choi et al.,
mids was transfected together with 5 mg of LTR vector or control plas-
1996). We demonstrate herein that transactivation of themid, plus 1 mg of pRSV-b-Gal as an internal transfection control.
collagenase IV gene by the Mo-MuLV LTR is independentb Transfections were performed with cotransfection of pML4 as the
LTR-containing plasmid (/) or with pBR322 (the backbone of pML4) of the physical location of the collagenase gene or of the
as a control (0). LTR, occurring whether the LTR or the collagenase gene
c CAT activity of pColCAT-60 plus pBR322 was assigned an arbitrary are integrated in the genome or transiently expressed.
value of 1. SEM is standard error of the mean.
Thus, this viral activity functions in trans, at a distance,
and is thus distinguishable from viral gene activation
secondary to the site of integration of the LTR or proviralintegrated MuLV LTR produced approximately 14-fold
genome.higher collagenase IV activity. Other, less prominent, pro-
The LTR-encoded transactivator of MuLV (designatedteolytic activities migrating at different molecular weights
let) was mapped by deletions and mutations to lie within(50, 78, 115, and 125 kDa) were also detected in the cell
the U3 region of the LTR (Choi and Faller, 1994), and thelines containing the viral LTR.
let transcript is initiated by RNA polymerase III, unlike
the tat or tax transactivators of HIV and HTLV (Choi andDISCUSSION
Faller, 1995). We have previously shown that the let tran-
We have previously demonstrated that infection of hu- script initiates within the LTR and not from any cryptic
man or murine cells with murine leukemia viruses rapidly cellular or plasmid initiation site (Choi and Faller, 1995).
The presence of this U3-specific let transcript in LTR-increases the transcription and expression of a number
FIG. 5. Collagenase production in response to MuLV LTR expression. (A) Immunoblot analysis of HeLa cell lysates using an anti-human collagenase
IV antibody. Cellular cytoplasmic lysates were harvested, separated on 10% SDS–PAGE, and then transferred to a nitrocellulose filter. The filter
was incubated with an anti-human collagenase IV antibody and developed as described under Materials and Methods. Lane 1, protein lysate from
HeLa cells containing an integrated MuLV LTR (LTR /); lane 2, protein lysate harvested from control HeLa cells (LTR 0); lane 3, molecular weight
markers (MW). The migration position of molecular weight markers (MW) is shown at the right. The migration position of the 92-kDa collagenase
IV protein is indicated. (B) Analysis of gelatinolytic activity in Balb/c-3T3 cell lysates by zymography. Cellular cytoplasmic protein lysates were
harvested and separated on a gelatin–acrylamide gel. The gel was washed in 2.5% Triton, incubated in substrate buffer, and then stained with
Coomasie blue. Lane 1, protein lysate harvested from Balb/c-3T3 cells (LTR 0). Lane 2, protein lysate harvested from Balb/c-3T3 cells expressing
an integrated MuLV LTR (LTR /). The migration position of molecular weight markers (MW) is shown at the right. The migration position of the 92-
kDa collagenase IV protein is indicated.
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containing cells was shown to correlate with the ability to scription factors, AP-1 and E1A-F (Angel et al., 1987;
transactivate endogenous cellular or transfected genes Schonthal et al., 1988; Chamberlain et al., 1993; Sato et
(Choi and Faller, 1995). Vectors containing isolated wild- al., 1993; Angel and Karin, 1992; Higashino et al., 1995).
type LTRs transactivated while vectors containing mu- The human collagenase IV promoter contains the TPA-
tated LTRs which did not transcribe let did not transacti- responsive element (TRE) (5*-TGAGTCA-3*), which is a
vate. The presence of this let transcript in cells with a binding site for transcription factor AP-1 (Angel et al.,
stably integrated LTR as detected by RT–PCR analysis
1987). Other, less-characterized cis-acting elements inand the ability of such cell lines to activate collagenase
the promoter may be important some species (Konig etIV is consistent with these previous findings. In addition,
al., 1992). For example, in the 5* flanking region of thea mutant LTR incapable of producing the let transcript
rabbit collagenase gene, two different cis-acting ele-did not result in collagenase IV transactivation.
ments, in addition to the TRE site, may be important inCollagenase IV is a member of the matrix metallopro-
mediating the TPA response. A polyoma virus enhancerteinase (MMP) family which has been identified in cell
cultures derived from malignant tumors as well as normal protein A (PEA) motif GAGGATGT located at 094 to 087
cells (Salo et al., 1981; Liotta et al., 1980; Poste and Fidler, bp and a third element (5*-TTCA-3*) at 0109 to 0106 bp
1980; Xia et al., 1996). Type IV collagen, the substrate for appeared to participate in mediating the full TPA re-
collagenase IV, is a major component of the basement sponse for the rabbit collagenase gene. The TRE element
membrane (Liotta et al., 1980, 1981). Many tumor cells alone was not sufficient to render the collagenase gene
have been found to secrete large amounts of this neutral TPA inducible but was important in maintaining the basal
metalloproteinase and collagenase IV thus plays an im-
level of expression (Auble and Brinckerhoff, 1991). In theportant role in the degradation of the basement mem-
system studied herein, however, the TRE element ap-brane, which constitutes the first step of the metastatic
peared both necessary and sufficient to mediate the in-cascade (Liotta et al., 1980, 1981; Salo et al., 1981; Brooks
duction by the Mo-MuLV LTR. Mo-MuLV trans-activateset al., 1996). Disruption of the tissue inhibitor of metallo-
transcription factor AP-1, stimulating both AP-1 DNA-proteinases in animals results in increased susceptibility
binding activity and the transcription of certain AP-1-in-to tumor invasion in experimental systems (Alexander
and Werb, 1992), and collagenase IV expression in a ducible genes (Weng et al., 1995). Transient or stable
transgenic mouse model increases susceptibility to tu- expression of the viral LTR alone also dramatically in-
morigenesis (Darmiento et al., 1995). In myeloid leukemic creases cellular AP-1 DNA-binding activity (Weng et al.,
cells, good correlations have been found between inva- 1995). Deletion and transversion mutations of the colla-
siveness, type IV collagenolysis, and collagenase IV pro- genase IV TRE demonstrated that this TRE consensus
duction (Watanabe et al., 1993). Increased expression site is required for transactivation of collagenase IV by
of 92-kDa collagenase IV in leukemic cell lines causes
the MuLV LTR. These findings strongly suggest thatincreased invasiveness of extramedullary tissues (Ko-
MuLV LTR activates collagenase IV through activation ofbayashi et al., 1995), and elevations in collagenase IV
transcription factor AP-1. Whether other AP-1-regulatedaffect tissue-specific localization of lymphoid cells (Hen-
proteases are similarly induced by Mo-MuLV remains todrix et al., 1992; Weeks et al., 1993a). The activation of
be determined, but the appearance of new proteolytictype IV collagenase by the Moloney leukemia virus, and
activities by zymography at molecular weights distinctmore specifically the retroviral LTR, in this report ex-
tended from the level of increased gene transcription from collagenase IV (92 kDa) in LTR-expressing cells
through to a functional increase in enzymatic activity. suggest that this may be the case.
This suggests that activation of proteolytic enzymes by The regulation of collagenase IV has been extensively
the MuLV LTR might play a contributory role in MuLV studied and takes place on at least three levels (Liotta
leukemogenesis and spread. We have shown herein that et al., 1987). The first level is transcriptional activation of
two relatively nonpathogenic viruses, AKV and Ampho- the collagenase IV gene, as previously described. The
tropic MuLVs, do not cause transactivation of collagen- second level of regulation is proteocleavage of the zymo-
ase IV, in contrast to the pathogenic Mo-MuLV. In unpub-
gen form of the enzyme. Collagenase IV is synthesizedlished work, we have found that several other pathogenic
in an inactive form, as a proenzyme (or zymogen), whichviruses, including Friend and Rauscher MuLVs, HTLV-I,
requires the removal of 80–84 amino acids at the amino-and HIV-1 (Choi et al., in preparation), also transactivate
terminal end for generation of proteolytic activity (Gold-collagenase IV, suggesting a correlation with pathoge-
berg et al., 1989). The third level of control of collagenasenicity. A definitive connection with the pathogenic effects
activity is through associations/dissociations with tissueof the viruses, however, awaits the results of ongoing
inhibitors of collagenase. After proteolytic activation, col-experiments in which the leukemogenic effects of a mu-
tant murine retrovirus incapable of transactivation are lagenase IV can be inactivated by forming a complex
studied. with a specific tissue inhibitor of metalloproteins, TIMP-
The induction of the human collagenase IV gene ex- 2 (Goldberg et al., 1989; Liotta et al., 1987; Imai et al.,
pression by inflammatory mediators, oncogenes, or phor- 1996). This ensures that the timing and magnitude of the
activation of tissue collagenases in normal tissues arebol esters can be regulated by at least two known tran-
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element located in the 5*-flanking region. Mol. Cell Biol. 7, 2256–tightly controlled. We found that the integration of MuLV
2266.LTR into cells stimulated a 9-fold increase of collagenase
Angel, P., Hattori, K., Smael, T., and Karin, M. (1988). The jun proto-
IV protein. The stimulation in collagenase IV activity by oncogene is positively autoregulated by its product, jun/AP-1. Cell
the LTR is therefore likely due in large part to an in- 55, 875–885.
Angel, P., and Karin, M. (1992). Specific members of the Jun proteincreased amount of collagenase IV protein. Other factors,
family regulate collagenase expression in response to various extra-however, may also be involved in the activation of colla-
cellular stimuli. Matrix Suppl. 1, 156–164.genase IV enzymatic activity. The effect of the MuLV and
Auble, D., and Brinckerhoff, C. E. (1991). The AP-1 sequence is neces-
its LTR on other regulatory steps including the pro- sary but not sufficient for phorbol induction of collagenase in fibro-
teocleavage of collagenase IV proenzyme and dissocia- blasts. Biochemistry 30, 4629–4636.
Belli, B., Wolff, L., Nazarov, V., and Fan, H. (1995). Proviral activation oftion of tissue inhibitors of metalloproteins remains to be
the c-myb proto-oncogene is detectable in preleukemic mice infecteddetermined.
neonatally with Moloney murine leukemia virus but not in resultingIn addition to a potential contributory role in tumor
end stage T lymphomas. J. Virol. 69, 5138–5141.
invasion and spread by leukemia virus induction of colla- Brightman, B. K., Davis, B. R., and Fan, H. (1990). Preleukemic hemato-
genase, the activation of tissue collagenase genes by poietic hyperplasia induced by Moloney murine leukemia virus is an
indirect consequence of viral infection. J. Virol. 64, 4582–4584.retroviruses may be relevant to another unexplained and
Brooks, P. C., Stromblad, S., Sanders, L. C., vonSchalscha, T. L., Aimes,intriguing disease caused by these nontransforming re-
R. T., Stetler-Stevenson, W. G., Quigley, J. P., and Cheresh, D. A.troviruses. The relationship between retroviral infection
(1996). Localization of matrix metalloproteinase MMP-2 to the surface
and development of chronic inflammatory diseases in of invasive cells by interaction with integrin alpha v beta 3. Cell 85,
murine models has long been documented (Izui et al., 683–693.
Cepko, C. L., Roberts, B. E., and Mulligan, R. C. (1984). Construction1984). A causal relationship between retroviral infection
and applications of a highly transmissible murine retrovirus shuttleand articular lesions in particular has been especially
vector. Cell 37, 1053–1062.well described. Type C retroviruses, like Mo-MuLV, can
Chamberlain, S. H., Hemmer, R. M., and Brinckerhoff, C. E. (1993). Novel
induce a lupus-like arthropathy in rodents. Lentiviruses, phorbol ester response region in the collagenase promoter binds
a subgroup of the retroviruses, cause chronic arthropathy Fos and Jun. J. Cell Biochem. 52, 337–351.
Chattopadhyay, S. K., Oliff, A. I., Linemeyer, D. L., Lander, M. R., andwith synovial hyperplasia in sheep and goats (Kennedy-
Lowy, D. R. (1981). Genomes of murine leukemia viruses isolatedStoskopf et al., 1987). There is mounting evidence for an
from wild mice. J. Virol. 39, 777–791.association between human T cell leukemia virus infec-
Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., and Rutter, W. J. (1979).
tion and autoimmune diseases, including rheumatoid ar- Isolation of biologically active ribonucleic acid from sources enriched
thritis, Sjogren’s syndrome, polymyositis, and systemic in ribonuclease. Biochemistry 18, 5294–5299.
Choi, S. Y., van de Mark, K. A., and Faller, D. V.(1996). Identification oflupus erythematosis [see (Wilder, 1994; Garry, 1994; Nel-
the cis-acting element of the class I Major Histocompatibility Com-son, 1995) for reviews]. An arthritis associated with the
plex promoter responsive to activation by retroviral sequences. J.human immunodeficiency virus (HIV) has also been re-
Virol., in press.
cently reported (Rowe and Keat, 1989). All of these ar- Choi, S. Y., and Faller, D. V. (1994). The long terminal repeats of a
thropathies are characterized by the formation of pannus- murine retrovirus encode a trans-activator for cellular genes. J. Biol.
Chem. 269, 19691–19694.like granulation tissue, with extensive erosive destruction
Choi, S. Y., and Faller, D. V. (1995). A transcript from the long terminalof cartilage and subchondral bone and elaboration of
repeats of a murine retrovirus associated with trans-activation ofmetalloproteases and gelatinases. Whether transactiva-
cellular genes. J. Virol. 69, 7054–7060.
tion of synovial fibroblast metalloprotease genes by the Chumakov, I., Stuhlmann, H., Harbers, K., and Jaenisch, R. J. (1982).
retroviral LTR contributes to this inflammatory and de- Cloning of two genetically transmitted Moloney leukemia proviral
genomes: correlation between biological activity of the cloned DNAstructive arthropathy remains to be determined.
and viral genome activation in the animal. J. Virol. 42, 1088–1098.
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